Fab'entech

Fab’entech is a biopharmaceutical company that develops immunotherapies. Based on its technology platform Fab’entech offers a biodefense antidote, a treatment for drug intoxication, and an Ebola therapy. The company also offers Fabenflu, a product indicated for the treatment of avian influenza (H5N1) in humans.